Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Invest Dermatol. 2019 Mar 12;139(9):1860–1866.e1. doi: 10.1016/j.jid.2019.01.034

Figure 2. Serum IgG autoantibody levels in BP patients with and without neurologic disease.

Figure 2.

Subjects were BP controls (BP CON), and BP patients with preceding neurologic disease (ND); Parkinson’s disease (PD+BP), dementia (DEM+BP), stroke (STR+BP). A) BP180- and B) BP230-specific IgG were measured by ELISA. The dashed line indicates the minimum value for a positive test, ≥ 9 Units/ml. Each point represents an individual patient. No statistically significant differences were observed.